Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic

Sponsor
Pierre and Marie Curie University (Other)
Overall Status
Completed
CT.gov ID
NCT04341714
Collaborator
(none)
450
1
3
150.5

Study Details

Study Description

Brief Summary

The COVID-19 pandemic has necessitated drastic measures in order to limit the spread of SARS-CoV-2. The stay home policies for the whole population and especially for frail patients and the express instruction to deprogram non-urgent consultations and interventions limited the clinic visits in neuro-urology department. In this context, telemedicine was seen as a pragmatic solution to provide follow-up care for our neurologic patients. Due to the delay in deploying telemedicine and the cognitive impairment of some of our patients, telephone consultation has been prioritized.

The COVID-19 pandemic might be an opportunity to review and refine our practices in neuro-urology. For the follow-up of selected patients, telephone consultations may be efficient and cost effective.

The aim of the study is to assess the efficiency and the satisfaction with telephone consultation for the physician and the patient.

The study was conducted in a neuro-urology department of a university hospital in France.

During the stay-home policies for the COVID-19 pandemic, all the scheduled medical visits were converted into telephone consultation. New patients weren't included.

For each teleconsultation, the physician assess the duration of the consultation, the number of tries to join the patient, the efficiency of the consultation, the difficulty to obtain relevant information due to the phone way of the consultation and the lack of physical examination.

On the next days, the patient was contacted by phone and was asked a) if he was satisfied of being phoned by the physician, b) if the teleconsultation was embarrassing, c) if he had enough time of teleconsultation d) if he got all the answers to his queries, e) if he would preferred to had a physical consultation f) to assessed the global satisfaction of the teleconsultation and g) if in the future, they may considered converting some clinic visits to teleconsultations.

The physician and the patient assessed whether this teleconsultation has replaced a physical visit.

The usual transport mode of the patient for a clinic visit and the need to take a day off for worker patients were recorded.

The primary aim was to assess the efficiency and the satisfaction of the telephone consultation. The primary outcome was the evaluation of the efficiency of the telephone consultation by the physician on a numerical 10-points scale. The secondary outcome was the evaluation of the satisfaction of the telephone consultation by the patient on a numerical 10-points scale.

Four hundred teleconsultations are scheduled for five physicians.

Condition or Disease Intervention/Treatment Phase
  • Other: Satisfaction evaluation

Study Design

Study Type:
Observational
Actual Enrollment :
450 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Efficiency and Satisfaction With Telephone Consultation in Neuro-urology: Experience of the COVID-19 Pandemic
Actual Study Start Date :
Mar 16, 2020
Actual Primary Completion Date :
May 30, 2020
Actual Study Completion Date :
Jun 15, 2020

Arms and Interventions

Arm Intervention/Treatment
patients enrolled

Patients with telephone consultation on neurourology department, age > 18

Other: Satisfaction evaluation
Assessement of satisfaction of the telephone consultation

Outcome Measures

Primary Outcome Measures

  1. Efficiency of the telephone consultation [1 day]

    The primary outcome was the evaluation of the efficiency of the telephone consultation by the physician on the numeric scale with 0 the worth efficiency and 10 the best efficiency.

Secondary Outcome Measures

  1. Satisfaction of the telephone consultation [1 day]

    The secondary outcome was the evaluation of the satisfaction of the telephone consultation by the patient onon the numeric scale with 0 the worth efficiency and 10 the best efficiency.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Age ≥ 18 years old

  • Telephone consultation

Exclusion Criteria:
  • New patient in the department

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Neuro- Urology, Hôpital Tenon Paris France 75020

Sponsors and Collaborators

  • Pierre and Marie Curie University

Investigators

  • Principal Investigator: Gérard Amarenco, PhD, Sorbonne Université, GRC 001, GREEN Groupe de Recherche en Neuro-Urologie, AP-HP, Hôpital Tenon, F-75020, Paris, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Gérard Amarenco, PHD, Pierre and Marie Curie University
ClinicalTrials.gov Identifier:
NCT04341714
Other Study ID Numbers:
  • GREEN GRC01
First Posted:
Apr 10, 2020
Last Update Posted:
Jun 15, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Gérard Amarenco, PHD, Pierre and Marie Curie University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2021